Dr. Bahija Jallal is Executive Vice President of AstraZeneca and head of MedImmune, the global biologics research and
development organization. She is a member of AstraZeneca’s senior executive team and joined MedImmune in March
Dr. Jallal is a member of the Board of Trustees of The Johns Hopkins University and the Board of Directors of the University
of Maryland Health Sciences Research Park Corporation.
Dr. Jallal has authored over 70 peer-reviewed publications and has more than 15 patents. She is a member of the American
Association of Cancer Research, the American Association of Science and the Pharmacogenomics Working Group and is the
President of the Board of Directors for the Association for Women in Science.
A continental breakfast will be served at 8:15 a.m.